• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H7N9 禽流感血凝素蛋白中的免疫逃逸适应性突变增加了病毒复制适应性并降低了大流行潜力。

Immune Escape Adaptive Mutations in the H7N9 Avian Influenza Hemagglutinin Protein Increase Virus Replication Fitness and Decrease Pandemic Potential.

机构信息

The Pirbright Institute, Pirbright, United Kingdom.

College of Veterinary Medicine, China Agricultural University, Beijing, China.

出版信息

J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00216-20.

DOI:10.1128/JVI.00216-20
PMID:32699084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7495387/
Abstract

H7N9 avian influenza viruses (AIVs) continue to evolve and remain a huge threat to human health and the poultry industry. Previously, serially passaging the H7N9 A/Anhui/1/2013 virus in the presence of homologous ferret antiserum resulted in immune escape viruses containing amino acid substitutions alanine to threonine at residues 125 (A125T) and 151 (A151T) and leucine to glutamine at residue 217 (L217Q) in the hemagglutinin (HA) protein. These HA mutations have also been found in field isolates in 2019. To investigate the potential threat of serum escape mutant viruses to humans and poultry, the impact of these HA substitutions, either individually or in combination, on receptor binding, pH of fusion, thermal stability, and virus replication were investigated. Our results showed the serum escape mutant formed large plaques in Madin-Darby canine kidney (MDCK) cells and grew robustly and They had a lower pH of fusion and increased thermal stability. Of note, the serum escape mutant completely lost the ability to bind to human-like receptor analogues. Further analysis revealed that N-linked glycosylation, as a result of A125T or A151T substitutions in HA, resulted in reduced receptor-binding avidity toward both human and avian-like receptor analogues, and the A125T+A151T mutations completely abolished human-like receptor binding. The L217Q mutation enhanced the H7N9 acid and thermal stability while the A151T mutation dramatically decreased H7N9 HA thermal stability. To conclude, H7N9 AIVs that contain A125T+A151T+L217Q mutations in the HA protein may pose a reduced pandemic risk but remain a heightened threat for poultry. Avian influenza H7N9 viruses have been causing disease outbreaks in poultry and humans. We previously determined that propagation of H7N9 virus in virus-specific antiserum gives rise to mutant viruses carrying mutations A125T+A151T+L217Q in their hemagglutinin protein, enabling the virus to overcome vaccine-induced immunity. As predicted, these immune escape mutations were also observed in the field viruses that likely emerged in the immunized or naturally exposed birds. This study demonstrates that the immune escape mutants also (i) gained greater replication ability in cultured cells and in chicken embryos as well as (ii) increased acid and thermal stability but (iii) lost preferences for binding to human-type receptor while maintaining binding for the avian-like receptor. Therefore, they potentially pose reduced pandemic risk. However, the emergent virus variants containing the indicated mutations remain a significant risk to poultry due to antigenic drift and improved fitness for poultry.

摘要

H7N9 禽流感病毒(AIVs)不断进化,仍然对人类健康和家禽业构成巨大威胁。以前,在同源雪貂抗血清存在的情况下,连续传代 H7N9 A/Anhui/1/2013 病毒会导致免疫逃逸病毒,其血凝素(HA)蛋白中含有氨基酸取代,即 125 位的丙氨酸到苏氨酸(A125T)和 151 位的丙氨酸到苏氨酸(A151T),以及 217 位的亮氨酸到谷氨酰胺(L217Q)。这些 HA 突变也在 2019 年的田间分离株中被发现。为了研究血清逃逸突变病毒对人类和家禽的潜在威胁,研究了这些 HA 取代物,无论是单独存在还是组合存在,对受体结合、融合 pH 值、热稳定性和病毒复制的影响。我们的结果表明,血清逃逸突变体在 Madin-Darby 犬肾(MDCK)细胞中形成大斑块,并大量生长,它们的融合 pH 值更低,热稳定性增加。值得注意的是,血清逃逸突变体完全丧失了与人类样受体类似物结合的能力。进一步分析表明,HA 中的 A125T 或 A151T 取代导致 N-连接糖基化,导致对人和禽样受体类似物的受体结合亲和力降低,而 A125T+A151T 突变完全消除了人类样受体结合。L217Q 突变增强了 H7N9 的酸稳定性和热稳定性,而 A151T 突变显著降低了 H7N9 HA 的热稳定性。总之,在 HA 蛋白中含有 A125T+A151T+L217Q 突变的 H7N9 AIVs 可能降低大流行风险,但对家禽仍构成高度威胁。禽流感 H7N9 病毒一直在家禽和人类中引起疾病爆发。我们之前确定,在病毒特异性抗血清中繁殖 H7N9 病毒会产生携带 HA 蛋白中 A125T+A151T+L217Q 突变的突变病毒,使病毒能够克服疫苗诱导的免疫。正如预测的那样,这些免疫逃逸突变也在可能出现在免疫或自然暴露的鸟类中的田间病毒中被观察到。这项研究表明,免疫逃逸突变体也(i)在培养细胞和鸡胚中获得了更强的复制能力,以及(ii)增加了酸稳定性和热稳定性,但(iii)丧失了对人类型受体的结合偏好,同时保持了对禽样受体的结合。因此,它们可能降低大流行风险。然而,由于抗原漂移和对家禽的适应性提高,含有上述突变的新出现病毒变体仍然对家禽构成重大风险。

相似文献

1
Immune Escape Adaptive Mutations in the H7N9 Avian Influenza Hemagglutinin Protein Increase Virus Replication Fitness and Decrease Pandemic Potential.H7N9 禽流感血凝素蛋白中的免疫逃逸适应性突变增加了病毒复制适应性并降低了大流行潜力。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00216-20.
2
Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.血凝素糖蛋白氨基酸残基 217 是禽流感 H7N9 病毒抗原性的关键介质。
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01627-18. Print 2019 Jan 1.
3
Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.针对 H7N9 禽流感病毒的治疗性人源单克隆抗体的抗原特性分析。
J Virol. 2023 Jan 31;97(1):e0143122. doi: 10.1128/jvi.01431-22. Epub 2022 Dec 21.
4
Risk assessment of the newly emerged H7N9 avian influenza viruses.新型 H7N9 禽流感病毒的风险评估。
Emerg Microbes Infect. 2023 Dec;12(1):2172965. doi: 10.1080/22221751.2023.2172965.
5
Immune Escape Variants of H9N2 Influenza Viruses Containing Deletions at the Hemagglutinin Receptor Binding Site Retain Fitness and Display Enhanced Zoonotic Characteristics.血凝素受体结合位点存在缺失的H9N2流感病毒免疫逃逸变体保持适应性并表现出增强的人畜共患病特征。
J Virol. 2017 Jun 26;91(14). doi: 10.1128/JVI.00218-17. Print 2017 Jul 15.
6
HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.H5N1 和 H7N9 流感病毒对人内皮细胞的 HA 依赖性嗜性由 HA 的稳定性降低决定,这使病毒能够应对内体酸化效率低下和组成型表达的 IFITM3。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01223-19.
7
A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.一个位于血凝素 218 位的氨基酸单点替换提高了流感 A(H7N9)候选疫苗病毒的生长能力。
J Virol. 2019 Sep 12;93(19). doi: 10.1128/JVI.00570-19. Print 2019 Oct 1.
8
Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.人感染期间观察到高致病性禽流感 H5N1 病毒受体结合位点内取代的表型效应。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00195-20.
9
The Origin of Internal Genes Contributes to the Replication and Transmission Fitness of H7N9 Avian Influenza Virus.内部基因的起源有助于 H7N9 禽流感病毒的复制和传播适应性。
J Virol. 2022 Nov 23;96(22):e0129022. doi: 10.1128/jvi.01290-22. Epub 2022 Nov 7.
10
L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.流感 H7N9 病毒血凝素上的 L226Q 突变增加了受体结合亲和力,并导致偏向性抗原性评估。
J Virol. 2020 Sep 29;94(20). doi: 10.1128/JVI.00667-20.

引用本文的文献

1
Influenza Virus Genomic Mutations, Host Barrier and Cross-species Transmission.流感病毒基因组突变、宿主屏障与跨物种传播
Curr Genomics. 2025;26(3):161-174. doi: 10.2174/0113892029316603240926051325. Epub 2024 Oct 11.
2
The haemagglutinin gene of bovine-origin H5N1 influenza viruses currently retains receptor-binding and pH-fusion characteristics of avian host phenotype.目前,牛源H5N1流感病毒的血凝素基因仍保留着禽类宿主表型的受体结合和pH融合特性。
Emerg Microbes Infect. 2025 Dec;14(1):2451052. doi: 10.1080/22221751.2025.2451052. Epub 2025 Jan 27.
3
Immunogenicity and Safety of AS03-Adjuvanted H7N9 Influenza Vaccine in Adults (18-64 and ≥65 Years): A Phase 1/2, Randomized, Placebo-Controlled Trial.

本文引用的文献

1
Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.鉴定第五波高致病性禽流感 A(H7N9)病毒的关键血凝素残基,这些残基负责病毒的裂解、酸稳定性和毒力。
Virology. 2019 Sep;535:232-240. doi: 10.1016/j.virol.2019.07.012. Epub 2019 Jul 12.
2
A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.一个位于血凝素 218 位的氨基酸单点替换提高了流感 A(H7N9)候选疫苗病毒的生长能力。
J Virol. 2019 Sep 12;93(19). doi: 10.1128/JVI.00570-19. Print 2019 Oct 1.
3
成人(18 - 64岁及≥65岁)中AS03佐剂H7N9流感疫苗的免疫原性和安全性:一项1/2期随机安慰剂对照试验
Influenza Other Respir Viruses. 2024 Dec;18(12):e70020. doi: 10.1111/irv.70020.
4
Evaluating the epizootic and zoonotic threat of an H7N9 low-pathogenicity avian influenza virus (LPAIV) variant associated with enhanced pathogenicity in turkeys.评估与火鸡致病性增强相关的 H7N9 低致病性禽流感病毒(LPAIV)变异株的动物流行病和人畜共患病威胁。
J Gen Virol. 2024 Jul;105(7). doi: 10.1099/jgv.0.002008.
5
Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift.H5 和 H7 禽流感病毒的 HA 和 NA 中的抗原漂移重要表位。
FEMS Microbiol Rev. 2024 May 8;48(3). doi: 10.1093/femsre/fuae014.
6
MDCK-Adaptive Mutation of A169S Changes Glycosylation Pattern of Hemagglutinin and Enhances MDCK-Based H7N9 Vaccine Virus Production without Loss of Antigenicity and Immunogenicity.A169S的MDCK适应性突变改变了血凝素的糖基化模式,并增强了基于MDCK的H7N9疫苗病毒的生产,且不损失抗原性和免疫原性。
Vaccines (Basel). 2024 Mar 11;12(3):291. doi: 10.3390/vaccines12030291.
7
Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes.呼吸道RNA病毒基因组中瞬时RNA结构与RNA聚合酶相互作用的演变
Virus Evol. 2023 Aug 26;9(2):vead056. doi: 10.1093/ve/vead056. eCollection 2023.
8
Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens.具有T169A突变的H7N9流感病毒血凝素具有更高的热稳定性,并能为鸡提供针对致死性H7N9病毒攻击的有效免疫保护。
Vaccines (Basel). 2023 Aug 2;11(8):1318. doi: 10.3390/vaccines11081318.
9
Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes.呼吸道RNA病毒基因组中瞬时RNA结构与RNA聚合酶相互作用的演变
bioRxiv. 2023 Aug 2:2023.05.25.542331. doi: 10.1101/2023.05.25.542331.
10
pH-dependent endocytosis mechanisms for influenza A and SARS-coronavirus.甲型流感病毒和严重急性呼吸综合征冠状病毒的pH依赖型内吞作用机制
Front Microbiol. 2023 May 10;14:1190463. doi: 10.3389/fmicb.2023.1190463. eCollection 2023.
The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019.
中国大陆 2019 年人感染高致病性禽流感 H7N9 病毒的再现。
Euro Surveill. 2019 May;24(21). doi: 10.2807/1560-7917.ES.2019.24.21.1900273.
4
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.从自然感染的人类中分离到的抗 H7N9 流感病毒的中和抗体的结构-功能分析。
Nat Microbiol. 2019 Feb;4(2):306-315. doi: 10.1038/s41564-018-0303-7. Epub 2018 Nov 26.
5
Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.哺乳动物模型中第五波 H7N9 流感病毒的风险评估。
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01740-18. Print 2019 Jan 1.
6
Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.血凝素糖蛋白氨基酸残基 217 是禽流感 H7N9 病毒抗原性的关键介质。
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01627-18. Print 2019 Jan 1.
7
Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017.2017 年在中国出现的 H7N9 高致病性病毒的快速演变。
Cell Host Microbe. 2018 Oct 10;24(4):558-568.e7. doi: 10.1016/j.chom.2018.08.006. Epub 2018 Sep 27.
8
Influenza Virus Segment Composition Influences Viral Stability in the Environment.流感病毒片段组成影响病毒在环境中的稳定性。
Front Microbiol. 2018 Jul 9;9:1496. doi: 10.3389/fmicb.2018.01496. eCollection 2018.
9
Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.流感血凝素蛋白的稳定性、激活及大流行风险
Trends Microbiol. 2018 Oct;26(10):841-853. doi: 10.1016/j.tim.2018.03.005. Epub 2018 Apr 19.
10
The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus.NHEJ-CRISPR/Cas9 和 Cre-Lox 系统在双价鸭肠炎病毒疫苗抗禽流感病毒中的应用。
Viruses. 2018 Feb 13;10(2):81. doi: 10.3390/v10020081.